Trevigen offers the following PARP inhibitors as controls for use in our Universal PARP Assays and Homogeneous PARP Exhibition Assay Kits.
3-Aminobenzamide
3-aminobenzamide is the control PARP inhibitor provided with Trevigen’s PARP Inhibition Assay Kits (Cat#s 4671-096-K, 4675-096-K, 4677-096-K, 4676-096-K) at 200 mM. 3-aminobenzamide attenuates tissue injury following transient ischemia.
4-Amino-1,8-naphthalimide
4-Amino-1,8-naphthalimide is a potent inhibitor of poly(ADP-ribose) polymer (PARP) and reduces ischemia-reperfusion injury in the heart and skeletal muscle. It is 1000-fold more potent that 3-aminobenzamide and exhibits mixed-type inhibition with respect to the sub-strate, NAD+, at micromolar concentrations.
6(5H)-Phenanthridinone
6(5H)-Phenanthridinone strongly inhibits poly(ADP-ribose) polymerase (PARP) and displays immunosuppressive activity. It is a mixed-type inhibitor that acts on both the enzyme and enzyme-NAD+ complex at site(s) distinct from the NAD+-binding site to attenuate the fall in NAD and ATP and, consequently, improve cell survival. It also inhibits concanavalin A-induced lymphocyte proliferation at micromolar concentrations.
Benzamide
Benzamide is the most potent poly(ADP-ribose) polymerase (PARP) inhibitor in the family of benzamides. It acts as a neuroprotectant since it inhibits PARP, an enzyme activated by peroxynitrite. Benzamide is twice as active than its commonly used counterpart, 3-aminobenzamide in delaying or suppressing PARP activation. It is able to prevent nuclear fragmentation and apoptotic-body formation without affecting DNA fragmentation during apoptosis.
|
|
Ordering Information
|
|
Catalog #:
|
Price:
|
|
4667-50-03
*200 mM 3-Aminobenzamide,
60 µl |
$75.00
|
|
4667-50-09
4-Amino-1;8-naphthalimide (800 µM),
100 µl |
$110.00
|
|
4667-50-10
6(5H)-Phenanthridinone (160 µM),
100 µl |
$110.00
|
|
4667-50-11
Benzamide (8 mM),
100 µl |
$110.00
|
|
Trevigen Products are now available for ordering through
|
- AND -
|
|
|
